4.7 Article

Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity

期刊

INTERNATIONAL JOURNAL OF PHARMACEUTICS
卷 382, 期 1-2, 页码 254-261

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ijpharm.2009.08.002

关键词

Liposome; Cationic lipid; Polyethylene glycol; Intracellular uptake

资金

  1. Ministry of Knowledge and Economy of South Korea [10016573]
  2. Korea Institute of Industrial Technology(KITECH) [10016573] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

Liposomes as one of the efficient drug carriers have some shortcomings such as their relatively short blood circulation time, fast clearance from human body by reticuloendothelial system (RES) and limited intracellular uptake to target cells. In this study, polyethylene glycol (PEG)-complexed cationic liposomes (PCL) were prepared by ionic complex of cationically charged liposomes with carboxylated polyethylene glycol (mPEG-COOH). The cationic liposomes had approximately 98.6 +/- 1.0 nm of mean particle diameter, and 45.5 +/- 1.1 mV of zeta potential value. While, the PCL had 110.1 +/- 1.2 nm of mean particle diameter and 18.4 +/- 0.8 mV of zeta potential value as a result of the ionic complex of mPEG-COOH with cationic liposomes. Loading efficiency of model drug, doxorubicin, into cationic liposomes or PCL was about 96.0 +/- 0.7%. Results of intracellular uptake evaluated by flow cytometry and fluorescence microscopy studies showed higher intracellular uptake of PCL than that of Doxil (R). In addition, in vitro cytotoxicity of PCL was comparable to cationic liposomes. in pharmacokinetic study in rats, PCL showed slightly lower plasma level of DOX than that of Doxil (R). In vivo antitumor activity of DOX-loaded PCL was comparable to that of Doxil (R) against human SKOV-3 ovarian adenocarcinoma xenograft rat model. Consequently, the PCL, of which surface was complexed with PEG by ionic complex may be applicable as drug delivery carriers for increasing therapeutic efficacy of anticancer drugs. (C) 2009 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据